Several statins widely used in clinical practice, such as atorvastatin, simvastatin, and lovastatin (and previously cerivastatin, now off the market because of very high incidence of rhabdomyolysis) [18], are metabolized by the cytochrome P450 (CYP)3A4 pathway. This evidence concerns the gene CYP3A4 and rhabdomyolysis.